Loading...
XSHG
603222
Market cap697mUSD
Dec 05, Last price  
9.39CNY
1D
1.08%
1Q
-10.66%
Jan 2017
-29.40%
IPO
125.49%
Name

Chimin Health Management Co Ltd

Chart & Performance

D1W1MN
XSHG:603222 chart
P/E
P/S
6.36
EPS
Div Yield, %
Shrs. gr., 5y
3.91%
Rev. gr., 5y
0.12%
Revenues
776m
-13.28%
548,363,132582,752,013559,420,132488,305,659448,595,640450,378,618602,898,708697,831,631771,279,230877,640,0181,098,469,879837,236,200894,508,694775,728,783
Net income
0k
P
67,775,03474,560,10581,247,75657,583,49051,747,10340,893,90452,884,35932,062,81869,198,6890147,521,34326,133,961-65,480,4170
CFO
73m
-47.94%
32,898,924169,879,357108,185,75677,356,24887,463,44672,115,82466,493,811123,987,469152,773,604166,292,926289,491,045204,653,775140,201,97572,985,921
Dividend
Jun 07, 20230.02 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Chimin Health Management Co., Ltd. develops, produces, and sells human drugs and medical devices in China. The company offers non-PVC soft bag double tube double valves, single valves, and single-tube double valves; plastic bottles; and other packaging forms. It also provides safety syringes, safety injection needles, sterile syringes, irrigators, dispensers, insulin syringes, infusion sets, precision filter infusion sets, and other products; In Vitro diagnosis solutions; and hemodialysis supplies, as well as medical services. The company was formerly known as Zhejiang Chimin Pharmaceutical Co.,Ltd. Chimin Health Management Co., Ltd. was founded in 1996 and is based in Huangyan, China.
IPO date
Feb 17, 2015
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT